Aller au contenu principal
Accès ouvert déclaré 2026 article

Temporal trends and regional variations in hepatocellular carcinoma etiology: a multinational study across Asia

2Citations signalées, ce qui n’est pas une note de qualité
60Institutions déclarées
12Pays d’affiliation déclarés

Rattachement africain : jp, mn, tr, kr, tw, id, cn, th, kz, ph, au, in. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

BACKGROUND: Hepatocellular carcinoma (HCC) remains a major health burden in Asia. Advances in antiviral therapies are reshaping the etiological landscape of HCC. This study evaluated temporal shifts in HCC etiology across Asian countries and their clinical implications. METHODS: This multinational study analyzed 6,261 newly diagnosed HCC patients registered in the APASL Hepatology/Oncology Consortium (A-HOC) from 19 centers across seven Asian countries and regions between 2013 and 2023. Data on demographics, tumor characteristics, etiology, and treatment patterns were collected. Etiologies included hepatitis B virus (HBV), hepatitis C virus (HCV), alcoholic liver disease (ALD), metabolic dysfunction-associated fatty liver disease (MAFLD), MAFLD plus excess alcoholic intake (MAFLD + eAL), autoimmune liver disease, cryptogenic, and others. Temporal trends and regional variations were assessed. RESULTS: In many countries, HBV remained predominant (43.3%-69.5%) and relatively stable throughout the period, while HCV showed only modest reductions. In Japan, HCV was the leading cause of HCC (33.1%), with a significant decline over time, accompanied by a rise in MAFLD-related HCC. ALD-related HCC increased in South Korea, and MAFLD-related HCC rose in Turkey. Tumor size and stage at diagnosis varied by etiology and region, affecting treatment strategies. Early-stage diagnosis was more frequent in Japan and Taiwan, whereas advanced-stage HCC was common in China and Indonesia. CONCLUSIONS: Distinct regional patterns and temporal changes in HCC etiology across Asia highlight the need for tailored prevention and surveillance measures. The growing burden of MAFLD-related HCC emphasizes its emerging role in liver cancer development, particularly in regions with declining viral hepatitis.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Temporal trends and regional variations in hepatocellular carcinoma etiology: a multinational study across Asia
Date Crossref
05/02/2026
Éditeur
Springer Science and Business Media LLC
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Okayama UniversityOkayama University HospitalUniversity of Tokyo HospitalThe University of TokyoTeikyo University Chiba Medical CenterYamanashi Prefectural Central HospitalMongolian National University of Medical SciencesMatsudo City HospitalChiba UniversityGazi UniversitySeoul National University HospitalKaohsiung Medical University Chung-Ho Memorial HospitalKagawa UniversityNagasaki Medical CenterDharmais Cancer HospitalBeijing Tsinghua Chang Gung HospitalYamagata UniversityNihon UniversitySiloam Eye HospitalSiriraj HospitalTaipei Veterans General HospitalJuntendo UniversityJapanese Red Cross Medical CenterRumah Sakit Umum Pusat Nasional Dr. Cipto MangunkusumoMahidol UniversityRamathibodi HospitalJR Tokyo General HospitalMitsui Memorial HospitalKhon Kaen UniversityChulalongkorn UniversityKing Chulalongkorn Memorial HospitalDicle UniversityÜmraniye Eğitim ve Araştırma HastanesiSağlık Bilimleri ÜniversitesiAnkara Bilkent City HospitalHacettepe UniversityAnkara UniversityKaradeniz Technical UniversityInonu UniversityFırat UniversityBahçeşehir UniversitySuleyman Demirel UniversityAtatürk UniversitySakarya UniversityUniversity of Santo Tomas HospitalDaehang HospitalPrince of Songkla UniversityNational Taiwan University HospitalThe University of QueenslandNanfang HospitalSouthern Medical UniversityGovind Ballabh Pant HospitalOur Lady of Fatima UniversityYonsei University Health SystemCapital Medical UniversityBeijing Friendship HospitalHumanity & HealthIstanbul Technical UniversityTsinghua UniversityInstitute of Liver and Biliary Sciences

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Hepatocellular Carcinoma Treatment and PrognosisHepatitis C virus researchLiver Disease Diagnosis and Treatment

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.